📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function (2019)

First Author: Kohn Donald B.

Attributed to: Phase I/II trial of lentiviral vector mediated gene therapy for Adenosine Deaminase deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 39

Parent Publication: JOURNAL OF CLINICAL IMMUNOLOGY

ISSN: 0271-9142